Evidence map›Paper›PMID 30084716›Full record

ArticleJournal of global oncology2018

Knowledge of Genetic Counseling Among Patients With Breast Cancer and Their Relatives at a Nigerian Teaching Hospital.

Prisca Adejumo, Toyin Aniagwu, Abimbola Oluwatosin, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Breast Cancer Risk in Women from Ghana Carrying Rare Germline Pathogenic Mutations.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2022
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Prisca AdejumoPrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Toyin AniagwuPrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Abimbola OluwatosinPrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Omolara FagbenlePrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Olubunmi AjayiPrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Dasola OgungbadePrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Adeyoola OluwamotemiPrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Funmilola Olatoye-WahabPrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Abiodun OniPrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Oluyemi OlajidePrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Babatunde AdedokunPrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Temidayo OgundiranPrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.
Olufunmilayo OlopadePrisca Adejumo, Abimbola Oluwatosin, Babatunde Adedokun, College of Medicine, University of Ibadan, Ibadan; Toyin Aniagwu, Omolara Fagbenle, Olubunmi Ajayi, Dasola Ogungbade, Adeyoola Oluwamotemi, Funmilola Olatoye-Wahab, Abiodun Oni, Oluyemi Olajide, and Temidayo Ogundiran, University College Hospital, Oyo, Nigeria; and Olufunmilayo Olopade, The University of Chicago, Chicago, IL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer prevalence continues to increase globally, and a significant proportion of the disease has been linked to genetic susceptibility. As we enter the era of precision medicine, genetics knowledge and skills are increasingly essential for achieving optimal cancer prevention and care. However, in Nigeria, patients with breast cancer and their relatives are less knowledgeable about genetic susceptibility to chronic diseases. This pilot study collected qualitative data during in-depth interviews with 21 participants. Of these, 19 participants were patients with breast cancer and two were relatives of patients with breast cancer. Participants were asked questions regarding their knowledge of breast cancer, views on heredity and breast cancer, and views on genetic counseling. Participants' family histories were used as a basis with which to assess their hereditary risk of breast cancer. Participant responses were audio recorded and transcribed manually. The study evaluated patients' and relatives' knowledge of genetic counseling and the use of family history for the assessment of familial risk of breast cancer. This will serve as a guide to the processes of establishing a cancer risk assessment clinic.

Indexed as

AdultAgedBreast NeoplasmsFemaleGenetic CounselingHospitals, TeachingHumansMiddle AgedNigeria

Identifiers

PMID30084716
PMCPMC6223535

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.